These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30473398)

  • 21. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 22. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 23. The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol.
    Coffman R; Johnson A; Frede S; Pleiman M; Johnson K
    J Am Pharm Assoc (2003); 2022; 62(4S):S35-S40.e1. PubMed ID: 34930681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of naloxone education for patients receiving buprenorphine-containing prescriptions indicated for opioid use disorder at an independent community pharmacy.
    Hines KL; Garofoli GK; Garofoli MP; Elswick BM; Winstanley EL
    J Am Pharm Assoc (2003); 2020; 60(6):e205-e214. PubMed ID: 32800678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.
    Lim JK; Bratberg JP; Davis CS; Green TC; Walley AY
    J Addict Med; 2016; 10(5):300-8. PubMed ID: 27261669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A standardized team-based approach for identifying naloxone-eligible patients in a grocery store pharmacy.
    Sexton SM; Armstrong A; Gatton O; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S95-S100. PubMed ID: 31231001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.
    Zaller ND; Yokell MA; Green TC; Gaggin J; Case P
    Subst Use Misuse; 2013 Jun; 48(8):590-9. PubMed ID: 23750660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a naloxone dispensing program in a grocery store-based community pharmacy.
    Wilkerson DM; Groves BK; Mehta BH
    Am J Health Syst Pharm; 2020 Mar; 77(7):511-514. PubMed ID: 32086505
    [No Abstract]   [Full Text] [Related]  

  • 29. How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities.
    Lai Joyce Chun K; Olsen A; Taing MW; Clavarino A; Hollingworth S; Dwyer R; Middleton M; Nielsen S
    Res Social Adm Pharm; 2019 Aug; 15(8):1014-1020. PubMed ID: 30926251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.
    Shoup JA; Mueller SR; Binswanger IA; Williams AV; Strang J; Glanz JM
    Pain Med; 2020 Oct; 21(10):2244-2252. PubMed ID: 32827044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The innovative role of an "opioid overdose prevention pharmacist" at a mental health teaching hospital.
    Costa T; Zhang M
    Am J Health Syst Pharm; 2021 Feb; 78(4):292-296. PubMed ID: 33471052
    [No Abstract]   [Full Text] [Related]  

  • 32. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
    Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
    [No Abstract]   [Full Text] [Related]  

  • 33. FIGHTING THE OPIOID CRISIS FROM THE FRONT LINE. How EMS can share data and partner with public health to help combat the overdose epidemic.
    Kinsman JM; Elder JM; Kanter JM
    EMS World; 2016 Oct; 45(10):25-8, 30-2, 34. PubMed ID: 29953755
    [No Abstract]   [Full Text] [Related]  

  • 34. Opioid overdose knowledge among college students compared to experienced opioid users.
    Jones JD; Avila JR; Smith MK; Martinez S
    Drug Alcohol Rev; 2024 Jan; 43(1):343-346. PubMed ID: 37920901
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving access to naloxone and opioid resources through the emergency department.
    Steenblik J; Jones A; Gold C; Seymour G; Garrett L; Griffith M; Blitch A; Langi S; Crump J; Madsen T
    Am J Emerg Med; 2023 Jun; 68():201-205. PubMed ID: 37061432
    [No Abstract]   [Full Text] [Related]  

  • 36. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A scoping review of post opioid-overdose interventions.
    Bagley SM; Schoenberger SF; Waye KM; Walley AY
    Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Take home naloxone for Ireland.
    Bury G
    Ir Med J; 2015 Mar; 108(3):70. PubMed ID: 25876295
    [No Abstract]   [Full Text] [Related]  

  • 39. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis.
    Antoniou T; Martins D; Campbell T; Tadrous M; Munro C; Leece P; Mamdani M; Juurlink DN; Gomes T
    Addiction; 2021 Jun; 116(6):1514-1520. PubMed ID: 33207025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.